Wake Forest, NC, United States of America

Janel Lape

This inventor holds 12 USPTO granted patents and 8 published patent applications and 5 EPO patents. Top assignee: Precision Biosciences, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janel Lape. Retrieved from https://idiyas.com/inventor/janel-lape

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 8)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 5(Granted Patents)

Company Filing History:

12 out of 56

Precision Biosciences, Inc.

patents

Years Active: 2021-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12752019 - ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HYDROXYACID OXIDASE 1 GENE (2026-10-06),

2. 12747430 - ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE TRANSTHYRETIN GENE (2026-09-29),

3. 12697400 - GENE EDITING METHODS FOR TREATING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY (2026-08-04),

4. 12655407 - ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME (2026-06-16),

5. 12410418 - Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2025-09-09),

6. 12006522 - Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene (2024-06-11),

7. 11993793 - Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene (2024-05-28),

8. 11788077 - Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2023-10-17),

9. 11786554 - Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene (2023-10-17),

10. 11753630 - Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene (2023-09-12),

11. 11680254 - Engineered meganucleases specific for recognition sequences in the PCSK9 gene (2023-06-20),

12. 11142750 - Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome (2021-10-12),

Title: The Innovative Journey of Janel Lape

Introduction: Janel Lape, a pioneering inventor based in Wake Forest, NC, has made significant contributions to the world of technology and innovation.

Latest Patents: Janel Lape holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the renewable energy sector, Janel Lape has led research teams in developing cutting-edge solutions for sustainable energy production. Her work has been recognized with multiple awards for innovation and environmental impact.

Collaborations: Throughout her career, Janel Lape has collaborated with leading universities and research institutions to further the development of renewable energy technologies. Her partnerships have resulted in groundbreaking advancements in the field.

Conclusion: Janel Lape's dedication to innovation and sustainability has positioned her as a trailblazer in the renewable energy industry, with a lasting impact on the future of clean energy solutions.

Profile summary based on public USPTO records.